QuantBioRes A/S: Financial statements 2024
CVR: 41407352
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
QuantBioRes A/S (CVR 41407352) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -820,130 and a net result of DKK -1,482,065 compared with DKK -1,342,114 the year before. Equity in the 2024 report amounted to DKK -8,835,213. The company had 1 employee in the financial year.
- Gross Profit
- DKK -820,130
- Profit/Loss
- DKK -1,482,065
- Equity
- DKK -8,835,213
- Total Assets
- DKK 883,176
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -820 t. | -1.5 mio. | -8.8 mio. | 1 |
| 2023 | - | -1.6 mio. | -1.3 mio. | -7.4 mio. | - |
| 2022 | - | -3.8 mio. | -3.1 mio. | -6 mio. | - |
| 2021 | - | -2.9 mio. | -2.3 mio. | -2.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
QuantBioRes A/S has published its annual report for 2023. Gross profit came to DKK -1,620,568, and the net result was DKK -1,342,114.
About QuantBioRes A/S
QuantBioRes A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Ivan Loncarevic. The board consists of Anthony Slingsby, Mark Andrew Madden and Novak Djokovic. The company is owned by Tulua Doo Beograd - Stari Grad, Anthony Charles Slingsby and Anna Eva Charlotta Slingsby. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,736,412 and a net result of DKK -2,396,479 compared with DKK -1,482,065 the year before. Equity in the 2025 report amounted to DKK 444,094.